Evaluation of the Potential Beneficial Effects of Ferula communis L. Extract Supplementation in Postmenopausal Discomfort.
Roberta MacrìJessica MaiuoloFederica ScaranoVincenzo MusolinoAnnalisa FregolaMicaela GliozziCristina CarresiSaverio NuceraMaria SerraRosamaria CaminitiAntonio CardamoneAnna Rita CoppolettaSara UssiaGiovanna RitortoValeria MazzaEzio BombardelliErnesto PalmaCarolina MuscoliVincenzo MollacePublished in: Nutrients (2024)
Peri-menopausal discomfort can have a detrimental effect on the physical health of women due to physiological and behavioral changes. Estrogen and progesterone-based hormone therapy can alleviate menopausal symptoms, but estrogen supplementation may have negative health effects. The effectiveness of hormone replacement therapy using natural compounds for peri-menopausal disorders is still uncertain. Evidence from in vivo experiments indicates that Ferula L. extract in ovariectomized rats leads to better sexual behavior. The effect seems to be linked to the phytoestrogenic properties of ferutinin, the primary bioactive compound in the extract. The purpose of this study was to assess the clinical impact of Ferula communis L. extract (titrated at 20% ferutinin, and given at doses of 100 mg/die for 90 days) on the quality of life of 64 menopausal women. The clinical trial was randomized, double-blind, and placebo controlled. Our data showed that Ferula communis L. extract reduced by 67 + 9% all symptoms associated to postmenopausal discomfort and enhanced significantly sexual behavior. In addition, the supplement led to a significant improvement of BMI and oxidative stress decrease in the women who received it, while also keeping platelet aggregation within normal levels. Overall, these results could point to the potential use of supplementation with Ferula communis L. extract to revert or mitigate menopause dysfunction.
Keyphrases
- oxidative stress
- double blind
- placebo controlled
- clinical trial
- polycystic ovary syndrome
- anti inflammatory
- replacement therapy
- mental health
- phase iii
- phase ii
- breast cancer risk
- healthcare
- randomized controlled trial
- pregnancy outcomes
- open label
- study protocol
- induced apoptosis
- dna damage
- systematic review
- ischemia reperfusion injury
- diabetic rats
- stem cells
- type diabetes
- social media
- cervical cancer screening
- sleep quality
- body mass index
- metabolic syndrome
- skeletal muscle
- phase ii study
- mesenchymal stem cells
- postmenopausal women
- depressive symptoms
- radiation therapy
- pregnant women
- insulin resistance
- cell therapy
- deep learning
- squamous cell carcinoma
- human health
- artificial intelligence
- health promotion